肥厚型心肌病心脏性猝死的预防 - Suppr

Suppr

超能文献

Prevention of sudden cardiac death in hypertrophic cardiomyopathy.

作者信息

O'Mahony Constantinos, Elliott Perry M

机构信息

The Inherited Cardiac Diseases Unit, The Heart Hospital/University College London, , London, UK.

出版信息

Heart. 2014 Feb;100(3):254-60. doi: 10.1136/heartjnl-2012-301996. Epub 2013 Apr 10.

DOI:10.1136/heartjnl-2012-301996

PMID:23574968

Abstract

摘要

相似文献

Prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Heart. 2014 Feb;100(3):254-60. doi: 10.1136/heartjnl-2012-301996. Epub 2013 Apr 10.

Sudden death and hypertrophic cardiomyopathy: a review.

Can J Cardiol. 2005 Apr;21(5):441-8.

Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.

Ann Noninvasive Electrocardiol. 2007 Apr;12(2):171-80. doi: 10.1111/j.1542-474X.2007.00157.x.

Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.

Eur Heart J. 2000 Dec;21(24):1979-83. doi: 10.1053/euhj.2000.2238.

Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:37-49.

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.

Circulation. 2003 Jun 17;107(23):2872-5. doi: 10.1161/01.CIR.0000072343.81530.75.

Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?

JAMA. 2007 Jul 25;298(4):452-4. doi: 10.1001/jama.298.4.452.

Sudden death in hypertrophic cardiomyopathy.

N Engl J Med. 2000 Feb 10;342(6):422-4. doi: 10.1056/NEJM200002103420609.

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

N Engl J Med. 2000 Feb 10;342(6):365-73. doi: 10.1056/NEJM200002103420601.

[Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].

Rev Esp Cardiol. 2007 Jul;60(7):784; author reply 785.

引用本文的文献

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator.

J Clin Med. 2022 Mar 16;11(6):1633. doi: 10.3390/jcm11061633.

Risk Stratification for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

Arq Bras Cardiol. 2021 Jul;117(1):157-159. doi: 10.36660/abc.20201339.

Hypertrophic Cardiomyopathy: A Review.

Arq Bras Cardiol. 2020 Nov;115(5):927-935. doi: 10.36660/abc.20190802.

Discrepancy between International Guidelines on the Criteria for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

Arq Bras Cardiol. 2020 Aug 28;115(2):197-204. doi: 10.36660/abc.20190161.

Risk Stratification in Hypertrophic Cardiomyopathy.

Eur Cardiol. 2015 Jul;10(1):31-36. doi: 10.15420/ecr.2015.10.01.31.

Amino Acid Changes at Arginine 204 of Troponin I Result in Increased Calcium Sensitivity of Force Development.

Front Physiol. 2016 Nov 15;7:520. doi: 10.3389/fphys.2016.00520. eCollection 2016.

Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance.

J Nucl Cardiol. 2016 Dec;23(6):1399-1410. doi: 10.1007/s12350-016-0595-z. Epub 2016 Jul 29.

Serum microRNA profiles in cats with hypertrophic cardiomyopathy.

Mol Cell Biochem. 2015 Apr;402(1-2):171-80. doi: 10.1007/s11010-014-2324-8. Epub 2015 Jan 9.

Inherited cardiomyopathies.

Circ J. 2014;78(10):2347-56. doi: 10.1253/circj.cj-14-0893. Epub 2014 Sep 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验